BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27529884)

  • 1. Effectiveness of Radioiodine Treatment for Toxic Nodular Goiter.
    Şakı H; Cengiz A; Yürekli Y
    Mol Imaging Radionucl Ther; 2015 Oct; 24(3):100-4. PubMed ID: 27529884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Results of Fixed High-Dose I-131 Treatment for Toxic Nodular Goiter: Higher Euthyroidism Rates in Geriatric Patients.
    Aktaş GE; Turoğlu HT; Erdil TY; İnanır S; Dede F
    Mol Imaging Radionucl Ther; 2015 Oct; 24(3):94-9. PubMed ID: 27529883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed 30 mCi (1110 MBq)
    Pereira LSB; Riguetto CM; Neto AM; Tambascia MA; Ramos CD; Zantut-Wittmann DE
    World J Nucl Med; 2021; 20(4):349-354. PubMed ID: 35018149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
    Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
    Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report.
    Yürekli Y; Cengiz A; Güney E
    Mol Imaging Radionucl Ther; 2015 Oct; 24(3):135-7. PubMed ID: 27529890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of different protocols of radioiodine therapy for treatment of toxic nodular goiter: systematic review and meta-analysis of the literature.
    Rokni H; Sadeghi R; Moossavi Z; Treglia G; Zakavi SR
    Int J Endocrinol Metab; 2014 Apr; 12(2):e14424. PubMed ID: 24803943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism.
    Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F
    J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
    Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
    Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of radioactive iodine treatment on 14C urea breath test results in patients with hyperthyroidism.
    Arduc A; Dogan BA; Ozuguz U; Tuna MM; Gokay F; Tutuncu YA; Isik S; Aydin Y; Peksoy I; Berker D; Guler S
    Clin Nucl Med; 2014 Dec; 39(12):1022-6. PubMed ID: 25036019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?
    Körber C; Schneider P; Körber-Hafner N; Hänscheid H; Reiners C
    Eur J Nucl Med; 2001 Sep; 28(9):1360-4. PubMed ID: 11585295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
    Chouhan A; Abhyankar A; Basu S
    Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine treatment of Plummer and multinodular toxic and nontoxic goiter disease by the first approximation dosimetry method.
    Zingrillo M; Urbano N; Suriano V; Modoni S
    Cancer Biother Radiopharm; 2007 Apr; 22(2):256-60. PubMed ID: 17600473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.
    Nygaard B; Hegedüs L; Nielsen KG; Ulriksen P; Hansen JM
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):197-202. PubMed ID: 10396362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.